A study in Europe has noted that nearly 15% of cancer patients who developed COVID-19 reported having long-term effects from the infection that had an adverse impact on their cancer outcomes.

At a median follow-up of 128 days, these patients had persistent respiratory symptoms, chronic fatigue, weight loss, and neuro-cognitive issues. A multivariable analysis adjusted for sex, age, comorbidities, tumor characteristics, anti-cancer therapy, and COVID-19 severity, revealed that the long-term sequelae were tied to a heightened risk of death (HR 1.76, 95% CI 1.16-2.66). In the study, around 15% of the patients reported at least one sequelae, which included respiratory symptoms in about 49.6% of patients, followed by fatigue in 41%, neuro-cognitive dysfunction in 7.3%, and weight loss in around 5.5%. It was more likely for these patients to be male, above 65 years of age, to have at least two comorbidities or a history of smoking, and to have COVID-19 that needed treatment or hospitalization… (Medpage Today)